Based on 7 reviews
I recently came across this company and I must say, I am impressed. The products are of high quality and have made a noticeable difference. The website is easy to navigate and provides all the necessary information. I would definitely recommend them to others.
😊 I am extremely satisfied with the products offered by Syndesi therapeutics. They have made a significant difference in my life. The website is user-friendly and provides all the necessary information. Keep up the good work! 💪
I recently started using their products and I am already seeing great results. The website is informative and easy to navigate. I would highly recommend trying out Syndesi therapeutics.
👍 Syndesi therapeutics is an amazing company! Their products have worked wonders for me. The website is user-friendly and provides detailed information about their offerings. Highly recommended! 👏
Syndesi therapeutics is a great company with innovative products. Their website syndesitherapeutics.com is very informative and user-friendly. I have been using their products for a while now and I am impressed with the results. The customer service is excellent and they always respond promptly to any queries. I highly recommend Syndesi therapeutics!
I have been using Syndesi therapeutics products for a few months now and they have been really effective. The website is well-designed and provides all the necessary information. I am happy with their products and would definitely recommend them to others. Keep up the good work!
I have been using their products for a few weeks now and I am extremely happy with the results. The website is user-friendly and provides detailed information about the products. I would highly recommend Syndesi therapeutics.
No news yet. This is where the business shares its own updates and press.
No photos yet. Photos shared by reviewers will show up here.
Syndesi Therapeutics is developing molecules that uniquely modulate the synaptic vesicle protein SV2A, which plays a central role in synaptic transmission (the communication between neurons in the brain). Regulating synaptic transmission represents a promising approach to treating Alzheimer’s Disease and other disorders with cognitive impairment. Syndesi has an exclusive license to its platform technology from UCB, the leading company in SV2A research.